Export

Swedish Orphan Biovitrum International AB

Financial information

The information source is the annual report of the company with business id 556329-5624

* Closing information (×1000) SEK

Fiscal year 202312 202212
Number of months: 12 12
Turnover: 23,253 Revenue Down 23,921 Revenue Up
Financial expenses: 92,684 Revenue Down 98,303 Revenue Up
Earnings before taxes: -65,126 Revenue Up -95,496 Revenue Up
Total assets: 5,638,753 Revenue Down 6,007,927 Revenue Up
Current assets: 34,453 Revenue Down 422,216 Revenue Up
Current liabilities: 103,237 Revenue Up 14,899 Revenue Down
Equity capital: 1,396,268 Revenue Up 1,234,535 Revenue Up
Share capital: 622 622
Number of employees: 0 0

Financial ratios

Solvency: 24.8% Revenue Up 20.5% Revenue Up
Turnover per employee: Infinity Infinity
Profitability: -280.1% Revenue Up -399.2% Revenue Up
Return on equity (ROE): -4.7% Revenue Up -7.7% Revenue Up
Current ratio: 33.4% Revenue Down 2.833.9% Revenue Up
Return on assets (ROA): 0.5% Revenue Up 0.0% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202312
Number of months: 12
Turnover: 23,253
Financial expenses: 92,684
Earnings before taxes: -65,126
Total assets: 5,638,753
Current assets: 34,453
Current liabilities: 103,237
Equity capital: 1,396,268
Share capital: 622
Number of employees: 0

Financial ratios

Solvency: 24.8%
Turnover per employee: Infinity
Profitability: -280.1%
Return on equity (ROE): -4.7%
Current ratio: 33.4%
Return on assets (ROA): 0.5%